Global Antimicrobial Peptides Supply, Demand and Key Producers, 2026-2032
Description
The global Antimicrobial Peptides market size is expected to reach $ 8.54 million by 2032, rising at a market growth of 5.3% CAGR during the forecast period (2026-2032).
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report studies the global Antimicrobial Peptides production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antimicrobial Peptides and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antimicrobial Peptides that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antimicrobial Peptides total production and demand, 2021-2032, (Mg)
Global Antimicrobial Peptides total production value, 2021-2032, (USD Million)
Global Antimicrobial Peptides production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Mg), (based on production site)
Global Antimicrobial Peptides consumption by region & country, CAGR, 2021-2032 & (Mg)
U.S. VS China: Antimicrobial Peptides domestic production, consumption, key domestic manufacturers and share
Global Antimicrobial Peptides production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Mg)
Global Antimicrobial Peptides production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Mg)
Global Antimicrobial Peptides production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Mg)
This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antimicrobial Peptides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Mg) and average price (US$/Mg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antimicrobial Peptides Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Antimicrobial Peptides Market, Segmentation by Type:
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Global Antimicrobial Peptides Market, Segmentation by Application:
Pharmaceuticals
Feed Additives
Others
Companies Profiled:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Key Questions Answered:
1. How big is the global Antimicrobial Peptides market?
2. What is the demand of the global Antimicrobial Peptides market?
3. What is the year over year growth of the global Antimicrobial Peptides market?
4. What is the production and production value of the global Antimicrobial Peptides market?
5. Who are the key producers in the global Antimicrobial Peptides market?
6. What are the growth factors driving the market demand?
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report studies the global Antimicrobial Peptides production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antimicrobial Peptides and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antimicrobial Peptides that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antimicrobial Peptides total production and demand, 2021-2032, (Mg)
Global Antimicrobial Peptides total production value, 2021-2032, (USD Million)
Global Antimicrobial Peptides production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Mg), (based on production site)
Global Antimicrobial Peptides consumption by region & country, CAGR, 2021-2032 & (Mg)
U.S. VS China: Antimicrobial Peptides domestic production, consumption, key domestic manufacturers and share
Global Antimicrobial Peptides production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Mg)
Global Antimicrobial Peptides production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Mg)
Global Antimicrobial Peptides production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Mg)
This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antimicrobial Peptides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Mg) and average price (US$/Mg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antimicrobial Peptides Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Antimicrobial Peptides Market, Segmentation by Type:
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Global Antimicrobial Peptides Market, Segmentation by Application:
Pharmaceuticals
Feed Additives
Others
Companies Profiled:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Key Questions Answered:
1. How big is the global Antimicrobial Peptides market?
2. What is the demand of the global Antimicrobial Peptides market?
3. What is the year over year growth of the global Antimicrobial Peptides market?
4. What is the production and production value of the global Antimicrobial Peptides market?
5. Who are the key producers in the global Antimicrobial Peptides market?
6. What are the growth factors driving the market demand?
Table of Contents
117 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
